Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000874015-07-000018
Filing Date
2007-02-05
Accepted
2007-02-05 18:11:55
Documents
2
Period of Report
2007-02-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 2310
2 POWER OF ATTORNEY jonaspoa.htm EX-24 3074
  Complete submission text file 0000874015-07-000018.txt   7320
Mailing Address 1896 RUTHERFORD ROAD CARLSBAD CA 92008
Business Address 1896 RUTHERFORD ROAD CARLSBAD CA 92008 7609319200
ISIS PHARMACEUTICALS INC (Issuer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ROBERTS SHERIDAN & KOTEL 12 EAST 49TH STREET 30TH FL NEW YORK NY 10017
Business Address AVAS TECHNOLOGIES INC 4520 MAIN STREET SUITE 930 KANSAS CITY MO 64111 8169601333
JONAS JEFFREY M (Reporting) CIK: 0001042021 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19125 | Film No.: 07581932